BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29145302)

  • 1. Burkitt lymphoma and cavernous sinus syndrome with breast uptake on 18F-FDG-PET/CT: A case report.
    Reyneke F; Mokgoro N; Vorster M; Sathekge M
    Medicine (Baltimore); 2017 Nov; 96(46):e8687. PubMed ID: 29145302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of Pretherapeutic
    Ding CY; Liu HY; Guo Z; Li TN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):438-443. PubMed ID: 28446289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT Imaging of Burkitt Lymphoma Presenting With Unusual Muscle Involvement.
    Dirlik Serim B; Gurleyen Eren T; Oz Puyan F; Durmus Altun G
    Clin Nucl Med; 2016 Aug; 41(8):643-5. PubMed ID: 27124681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT in Extranodal Burkitt Lymphoma.
    Jiménez Granero P; García Gómez FJ; Ruiz Mercado M; Borrego Dorado I
    Clin Nucl Med; 2015 Sep; 40(9):748-9. PubMed ID: 26098290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma.
    Albano D; Bosio G; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):87-96. PubMed ID: 30276438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Breast Lymphoma Mimicking Metastatic Breast Cancer on 18F-FDG PET-CT.
    Usmani S; Albader FL; Marafi F; Elhaggracy RS
    J Pak Med Assoc; 2022 Jun; 72(6):1241-1242. PubMed ID: 35751349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma.
    Wei WX; Huang JJ; Li WY; Zhang X; Xia Y; Jiang WQ; Fan W; Li ZM
    Chin J Cancer; 2015 Dec; 34(12):608-13. PubMed ID: 26630874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse Infiltration of Multiple Myeloma With Initial Manifestation of Cavernous Sinus Syndrome Unveiled by 18F-FDG PET/CT.
    Li C; Shao F; Yang Y; Lan X
    Clin Nucl Med; 2019 Sep; 44(9):746-747. PubMed ID: 31306198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.
    Ömür Ö; Baran Y; Oral A; Ceylan Y
    Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT.
    Davidson T; Priel E; Schiby G; Raskin S; Chikman B; Nissan E; Benjamini O; Nissan J; Goshen E; Ben-Haim S; Salomon O; Avigdor A
    Abdom Radiol (NY); 2018 Sep; 43(9):2369-2374. PubMed ID: 29460043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma.
    Riad R; Omar W; Sidhom I; Zamzam M; Zaky I; Hafez M; Abdel-Dayem HM
    Nucl Med Commun; 2010 Mar; 31(3):232-8. PubMed ID: 20032800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
    Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J
    Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Uterine Peripheral T-cell Lymphoma: A Case Report of MRI and 18F-FDG PET/CT Findings.
    Gong J; Dong A; Wang Y; Zhang X; Yang P; Wang L; Jing W
    Medicine (Baltimore); 2016 Apr; 95(17):e3532. PubMed ID: 27124063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkitt Lymphoma/Leukemia Presented on 68Ga-Pentixafor and 18F-FDG PET/CT.
    Chen Z; Xue Q; Huang C; Yao S; Miao W
    Clin Nucl Med; 2022 Jan; 47(1):98-100. PubMed ID: 34115701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge.
    Hsiao YS; Shen SC; Hsiao SC
    Am J Case Rep; 2024 Apr; 25():e943275. PubMed ID: 38644602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone metastases with "false negative" findings on 18F-FDG PET/CT in patients with angiosarcoma: A case series with literature review.
    Ariga A; Matsumoto S; Tanizawa T; Hayakawa K; Minami Y; Saito M; Kurosawa N; Yamashita K; Terauchi T; Ae K
    Medicine (Baltimore); 2023 Jul; 102(28):e34196. PubMed ID: 37443509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
    Kandeel AA; Hussein M; Zidan L; Younis J; Edesa W; Alsayed Y
    Nucl Med Commun; 2020 Mar; 41(3):269-279. PubMed ID: 31895758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.